PO Box 58871
London SE15 9BE, UK
info@cedillapublishing.com
+44 (0)7794 485294


Cedilla Publishing highly commended at 2016 BMA Medical Book Awards
We are delighted to announce that our GP pain handbook, The 10-minute consultation: persistent pain, was highly commended in the primary health care category at the 2016 BMA Medical Book Awards.

The GP judging panel commented:
"Pain management is an increasingly challenging field in general practice and this [guide] brings together a lot of useful information. It is comprehensive while concise and includes a good range from the best scientific evidence through to holistic approaches. I checked some of the sections and found them to be both accurate and up-to-date. It is a good introduction to the subject."

If you are interested in purchasing copies or translation rights, please contact Sarah Findlay on +44 (0)7794 485294 or email info@cedillapublishing.com.

News Archive

Asthma: Young people in the UK 'more likely to die'
Wed, 20 Feb 2019 00:00:37 GMT
The UK lags behind other wealthy nations across a number of health indicators, a report finds.
Sepsis test could show results 'in minutes'
Tue, 19 Feb 2019 17:15:11 GMT
Researchers are developing a test they hope will one day help detect the condition in minutes.
Shark DNA could help cure cancer and age-related illnesses in humans
Tue, 19 Feb 2019 15:34:06 GMT
A new study maps the DNA of sharks and experts believe their genes could help cure human diseases.
NHS implements new AI code of conduct
Thu, 21 Feb 2019 11:39:50 +0000
A new code of conduct will ensure that only the best and safest data-driven technologies are used by the NHS, the government says.
Young people in UK ?suffering from long-term conditions? despite healthier life choices
Thu, 21 Feb 2019 11:20:29 +0000
Young people in the UK are making healthier life choices for themselves than before, but are more likely to have a poor quality of life, a new study has found.
Cell therapy trial shows 'significant' vision restoration
Thu, 21 Feb 2019 11:19:06 +0000
ReNeuron has found ‘significant restoration of vision’ in patients with retinitis pigmentosa given its human retinal progenitor cells (hRPC) cell therapy.